WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H576352
CAS#: 18679-90-8
Description: Hopantenic acid is a nootropic agent.
Hodoodo Cat#: H576352
Name: Hopantenic acid
CAS#: 18679-90-8
Chemical Formula: C10H19NO5
Exact Mass: 233.13
Molecular Weight: 233.260
Elemental Analysis: C, 51.49; H, 8.21; N, 6.00; O, 34.29
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Hopantenic acid
IUPAC/Chemical Name: D-(+)-4-(2,4-Dihydroxy-3,3-dimethylbutyramido)butyric acid
InChi Key: SBBDHANTMHIRGW-QMMMGPOBSA-N
InChi Code: InChI=1S/C10H19NO5/c1-10(2,6-12)8(15)9(16)11-5-3-4-7(13)14/h8,12,15H,3-6H2,1-2H3,(H,11,16)(H,13,14)/t8-/m0/s1
SMILES Code: CC(C)(CO)[C@@H](O)C(=O)NCCCC(=O)O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 233.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1. Nakano K, Ando H, Sugawara Y, Ohashi M, Harigaya S. Hopantenic acid beta-glucoside as a new urinary metabolite of calcium hopantenate in dogs. Drug Metab Dispos. 1986 Nov-Dec;14(6):740-5. PMID: 2877836.
2. Gromova OA, Troshin IY, Limanova OA, Gromov AN, Fedotova LE, Rudakov KV. Neĭrotropnye, protivovospalitel'nye i protivoopukholevye svoĭstva molekuly gopantenovoĭ kisloty po dannym khemoinformatsionnogo analiza [Neurotropic, anti-inflammatory and antitumor properties of hopantenic acid: a chemoinformatic analysis of its molecule]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(5 Pt 2):61-71. Russian. doi: 10.17116/jnevro20151155261-71. PMID: 26356282.